Difference between revisions of "Patent Reform"
imported>Jackie |
imported>Julia |
||
Line 25: | Line 25: | ||
**Aimed at reducing cost | **Aimed at reducing cost | ||
− | '''S.1137: Protecting American Talent and Entrepreneurship (PATENT) Act''' [ | + | '''S.1137: Protecting American Talent and Entrepreneurship (PATENT) Act''' [https://www.congress.gov/bill/114th-congress/senate-bill/1137 (Congress)] |
Revision as of 14:38, 19 February 2016
Contents
Problems with Current Patent System
- Many patents are approved because examiners don’t have time or resources to search all the relevant references
- “The past three decades of wanton patent-granting have created a disastrous environment for innovation. Today it’s practically impossible to build anything without violating a patent of some kind—and risking a multimillion-dollar lawsuit for your troubles.” (Wired)
- Technology industry has too many overly broad patents, leading to incredibly silly patent litigation cases
- Amazon “owns” the process that allows people to buy things with a single click.
- Apple now claims the exclusive right to sell rounded-edged, rectangular-shaped communication devices on which icons are arranged in a grid with a row of persistent icons at the bottom
- A small company in Tyler, Texas, once demanded more than $600 million from Google because of the design of the borders around its display ads.
- ‘’’Patent Trolls’’’ are nonpracticing entities that don’t make products but exist solely on the revenue of its patents
- Costs a few thousand dollars to secure a patent, which can bring in millions through litigation
- It is usually more expensive to win a case against a troll than to just settle
- Last year, for the first time, spending by Apple and Google on patent lawsuits and unusually big-dollar patent purchases exceeded spending on research and development of new products, according to public filings. (NYT-PW)
- Me-too drugs: a drug that is approved after a pioneering drug and is the 'same'; it is not clinically superior to the original drug (WHO)
Current Reform
Legislation
H.R.9: Innovation Act (Congress)
- Heightened pleading requirements: must show how each limitation of each asserted claim in each asserted patent is found within each
- Presumption of attorney fees: encourages judges to make a party pay attorney fees if lawsuit or claim is deemed frivolous
- Transparency of ownership: requires plaintiffs to disclose the owner of the patent in question so the identity of the real parties behind the litigation is clear
- Will ensure that patent trolls cannot hide behind a web of shell companies to avoid accountability for bringing frivolous litigation
- Discovery limits: limit discovery in litigation until after a claim construction ruling
- Aimed at reducing cost
S.1137: Protecting American Talent and Entrepreneurship (PATENT) Act (Congress)
H.R.1249: Leahy Smith America Invents Act (2011) [1]
Failed Legislation
H.R.845: The Shield (Saving High-Tech Innovators From Egregious Legal Disputes) Act [2]
- Introduced in 2013, but was not enacted
- Requires an unsuccessful plaintiff in an infringement suit to pay the defendant’s legal fees
- Effort to dissuade frivolous patent lawsuits
Prize System for Inventions
The current patent system allows companies to file for the right to exclude if they have a novel, non-obvious invention. The right to exclude creates a temporary monopoly for a certain product, which leads to higher product costs for the consumer. One example of a patent leading to exorbitantly high prices would be Daraprim, a drug produced by Turing Pharmaceuticals. Martin Shkreli, the CEO of Turing Pharmaceuticals, led the charge to increase the price of Daraprim from $13.50 to $750 per pill. [3]
Because of such abuses of patent protections, economists and legislators have advocated for a prize system instead of a patent system for pharmaceutical drugs.[4] Under this system, companies that invent a new drug will receive a lump sum prize. The rights to the drug will then be placed in the public domain, creating generic drugs.